# Ocular Therapeutix, Inc. (OCUL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/OCUL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 10.79M | $ -88.61M | $ -70.66M | $ 79.46M | $ 581.57M |
| 2025 | $ 53.19M | $ -272.30M | $ -222.08M | $ 76.97M | $ 654.31M |
| 2024 | $ 66.98M | $ -203.39M | $ -142.91M | $ 75.78M | $ 315.34M |
| 2023 | $ 63.19M | $ -87.30M | $ -88.13M | $ 83.39M | $ 91.13M |
| 2022 | $ 57.52M | $ -79.36M | $ -70.73M | $ 64.28M | $ 35.38M |
| 2021 | $ 51.73M | $ -7.79M | $ -79.34M | $ 58.98M | $ 88.00M |
| 2020 | $ 22.17M | $ -198.27M | $ -69.30M | $ 58.44M | $ 76.10M |
| 2019 | $ 5.46M | $ -111.48M | $ -103.02M | $ 59.34M | $ -3.63M |
| 2018 | $ 2.63M | $ -79.21M | $ -67.51M | $ 24.79M | $ 35.88M |
| 2017 | $ 2.59M | $ -85.39M | $ -79.11M | $ 18.02M | $ 26.15M |
| 2016 | $ 2.60M | $ -61.50M | $ -49.42M | $ 15.64M | $ 52.01M |
| 2015 | $ 2.46M | $ -55.81M | $ -49.87M | $ 15.27M | $ 89.59M |
| 2014 | $ 1.09M | $ -40.48M | $ -30.74M | $ 14.87M | $ 58.70M |
| 2013 | $ 0 | $ -18.94M | $ -18.53M | $ 2.46M | $ -59.47M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.14 |
| Liabilities / Eq | 0.26 |
| Current Ratio | 14.81 |

## Other views

- [Metrics](https://sponda.capital/en/OCUL.md)
- [Charts](https://sponda.capital/en/OCUL/charts.md)
- [Compare](https://sponda.capital/en/OCUL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.